MYH4 Antibody

What is MYH4 and why is it important in muscle research?

MYH4 represents myosin heavy chain 4, a skeletal muscle protein that functions in muscle contraction. It is one of the most important proteins in skeletal muscle tissue and serves as a critical marker for specific muscle fiber types . MYH4 is particularly significant in research focused on muscle composition, development, and pathology as it helps identify type IIB fast-twitch glycolytic fibers. The ability to accurately detect and quantify MYH4 expression enables researchers to characterize muscle fiber composition changes during development, aging, exercise adaptation, and in various muscular disorders.

What are the common applications for MYH4 antibodies?

MYH4 antibodies are utilized across multiple experimental applications in muscle research:

These applications allow researchers to investigate MYH4 expression in various contexts, from protein quantification to spatial distribution within muscle tissues . For optimal results, each application requires specific optimization based on sample type and experimental conditions.

What species reactivity can be expected with MYH4 antibodies?

Most commercially available MYH4 antibodies demonstrate confirmed reactivity with human, mouse, and rat samples . Some antibodies have also been cited to react with pig and canine samples, though with varying specificity . When selecting an antibody for your research, it's crucial to verify the documented species reactivity and consider cross-validation if working with less commonly tested species. The amino acid sequence homology between species should be evaluated when considering antibody applications across different model organisms.

How should muscle samples be prepared for optimal MYH4 antibody staining?

Proper sample preparation is essential for successful MYH4 antibody staining. For muscle tissue sections:

• Fix freshly collected tissue in 4% paraformaldehyde or appropriate fixative

• Process and embed tissue (paraffin or frozen sections as appropriate)

• For paraffin sections, perform heat-mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes

• Rehydrate sections in PBS for 10 minutes and optionally permeabilize with 0.3% Triton X-100/PBS briefly

• Block sections with 5% goat serum in PBS for 10 minutes to reduce non-specific binding

• Apply primary antibody at recommended dilution (typically 1:20-1:200 for IHC)

• Incubate overnight at 4°C for optimal binding

• Wash thoroughly with PBS (3 × 5 minutes) before applying appropriate secondary antibody

This protocol ensures optimal antigen preservation and accessibility for the antibody, resulting in specific staining of MYH4-expressing muscle fibers. The choice between frozen and paraffin sections depends on the specific experimental requirements and antibody compatibility.

What controls should be included when using MYH4 antibodies?

Rigorous experimental design requires appropriate controls:

• Positive tissue control: Include known MYH4-expressing tissue (skeletal muscle tissue from human, mouse, or rat)

• Negative tissue control: Use tissues known not to express MYH4 (e.g., human liver)

• Secondary antibody-only control: Omit primary antibody but include all other steps to assess non-specific binding

• Isotype control: Include an irrelevant antibody of the same isotype to evaluate non-specific binding

• Validation control: When possible, include samples from MYH4 knockout models or siRNA knockdown experiments

When publishing results, these controls demonstrate antibody specificity and validate experimental findings. Documentation of these controls is increasingly required by high-impact journals to ensure reproducibility of immunostaining results.

How can I simultaneously detect multiple myosin heavy chain isoforms including MYH4?

To comprehensively analyze muscle fiber types, researchers often need to detect multiple myosin heavy chain isoforms simultaneously:

• Select primary antibodies raised in different host species or of different isotypes (e.g., MYH7, MYH2, and MYH4)

• Prepare an antibody cocktail with optimized concentrations of each antibody

• Apply the primary antibody cocktail to muscle sections and incubate overnight at 4°C

• Wash thoroughly with PBS (3 × 5 minutes)

• Apply isotype-specific or species-specific secondary antibodies conjugated to different fluorophores

• Counterstain with DAPI or other nuclear markers if desired

• Mount slides with appropriate anti-fade mounting medium

This approach allows simultaneous visualization of type I (MYH7-positive), type IIA (MYH2-positive), and type IIB (MYH4-positive) fibers, while unstained fibers can be identified as type IIX . Image analysis software can then be used to quantify fiber type distribution and cross-sectional areas.

How do I address potential cross-reactivity between MYH4 and other myosin heavy chain isoforms?

Cross-reactivity is a significant concern when working with myosin heavy chain antibodies due to sequence homology between isoforms:

• Antibody selection: Choose antibodies raised against unique peptide sequences specific to MYH4

• Validation approach: Employ orthogonal validation techniques:

  • Compare results from multiple independent antibodies targeting different MYH4 epitopes

  • Validate antibody specificity using mass spectrometry to confirm isoform identity

  • Use tissue from knockout models or after gene silencing to confirm specificity

• Complementary techniques: Combine antibody-based detection with mRNA analysis (qPCR or in situ hybridization)

• Pre-adsorption test: When cross-reactivity is suspected, pre-incubate the antibody with purified antigen to confirm specificity

Research has shown that antibodies advertised as "specific" can cross-react with other myosin isoforms, as demonstrated by studies showing that anti-MYH6 antibodies may cross-react with MYH7 due to 87% sequence identity in the immunogen region . Mass spectrometry analysis of unique peptides can provide more definitive identification of specific myosin isoforms present in samples.

What are the best approaches for quantifying MYH4 expression in heterogeneous muscle samples?

Accurate quantification of MYH4 in mixed fiber-type muscles requires specialized approaches:

• Laser capture microdissection (LCM): Isolate specific fiber types based on morphology or preliminary staining

• Fiber type-specific analysis: Process isolated fibers for:

  • Mass spectrometry to identify and quantify myosin isoforms based on unique peptides

  • Western blotting with carefully validated antibodies

  • RNA-seq or qPCR for transcript-level analysis

• Image analysis of sectioned tissue:

  • Perform immunofluorescence with fiber type-specific antibodies

  • Use automated image analysis software to quantify fiber-specific expression

  • Calculate percentage area, intensity, and distribution of MYH4-positive fibers

Research has demonstrated that individual muscle fibers may contain mixtures of myosin heavy chain isoforms, challenging the traditional classification system . Quantifying the relative abundance of each isoform requires techniques capable of resolving this heterogeneity at the single-fiber level.

How can I interpret contradictory MYH4 expression data between antibody-based and mass spectrometry methods?

When facing contradictory results between different detection methods:

• Evaluate antibody validation: Check if the antibody has undergone enhanced validation (siRNA knockdown, tagged GFP cell lines, or independent antibodies)

• Consider detection sensitivity: Mass spectrometry may detect low-abundance proteins that fall below antibody detection thresholds

• Analyze post-translational modifications: These may affect antibody binding but not peptide identification by mass spectrometry

• Examine splice variants: Different detection methods may preferentially detect specific protein isoforms

• Implement complementary approaches:

  • Combine protein-level detection with transcript analysis

  • Use multiple antibodies targeting different epitopes

  • Apply quantitative mass spectrometry with multiple unique peptides per protein

Research has shown that mass spectrometry can detect MYH4 in fiber types where it wasn't previously identified by immunohistochemistry alone . This discrepancy highlights the importance of using multiple methodological approaches when studying complex protein expression patterns.

What are the methodological considerations for studying MYH4 in human versus rodent models?

Important differences exist when studying MYH4 across species:

When transitioning between species:

• Verify antibody epitope conservation across species

• Optimize antibody concentration and incubation conditions for each species

• Consider species-specific differences in fiber type distribution and muscle composition

• Use species-appropriate positive and negative controls

• Account for potential differences in tissue preparation requirements

Human skeletal muscle research often presents additional challenges due to sample heterogeneity, variability in fiber type composition, and limited sample availability compared to controlled rodent studies.

What are common causes of weak or absent MYH4 antibody staining?

When experiencing suboptimal MYH4 staining:

• Fixation issues: Overfixation can mask epitopes; optimize fixation duration and conditions

• Ineffective antigen retrieval: Try alternative methods:

  • Heat-mediated retrieval with Tris-EDTA buffer (pH 9.0)

  • Alternative retrieval with citrate buffer (pH 6.0)

• Antibody dilution: Titrate antibody concentrations to determine optimal working dilution

• Incubation conditions: Extend primary antibody incubation time (overnight at 4°C vs. 1-2 hours)

• Detection system sensitivity: Consider amplification systems for low-abundance targets

• Sample quality: Ensure tissues were properly collected, fixed, and stored

• Antibody quality: Check antibody stability, storage conditions, and expiration date

Each experimental system requires optimization for reliable results. It is recommended that reagents should be titrated in each testing system to obtain optimal results .

How can I minimize background when using MYH4 antibodies in immunostaining?

High background can compromise result interpretation. To minimize non-specific staining:

• Optimize blocking: Use 5% normal serum from the same species as the secondary antibody

• Increase washing: Perform thorough washing steps (3-5 × 5 minutes each)

• Adjust antibody concentration: Dilute primary and secondary antibodies appropriately

• Pre-adsorb secondary antibodies: Use secondaries pre-adsorbed against tissues from other species

• Block endogenous peroxidase: For HRP-based detection, quench endogenous peroxidase activity

• Block endogenous biotin: For biotin-based detection systems, block endogenous biotin

• Optimize incubation temperature: Room temperature incubation may reduce non-specific binding

• Use appropriate negative controls: Include secondary-only and isotype controls to assess background

The optimal approach will depend on the specific tissues, antibodies, and detection systems being used. Systematic optimization of each parameter may be necessary for challenging samples or low-abundance targets.

What storage conditions ensure long-term stability of MYH4 antibodies?

Proper storage is essential for maintaining antibody performance over time:

• Store antibodies at -20°C for long-term storage

• Avoid repeated freeze-thaw cycles by preparing small aliquots

• For antibodies in glycerol-containing buffers (typical storage buffer: PBS with 0.02% sodium azide and 50% glycerol, pH 7.3), aliquoting may be unnecessary for -20°C storage

• Working dilutions should be prepared fresh and used within 24 hours

• Always centrifuge antibody vials briefly before opening to collect liquid at the bottom

• Follow manufacturer's specific recommendations for each antibody

• Monitor antibody performance over time using consistent positive controls

How can MYH4 antibodies be used in single-cell analysis of skeletal muscle?

Emerging single-cell technologies offer new applications for MYH4 antibodies:

• Single-cell protein profiling:

  • Flow cytometry of isolated muscle nuclei with MYH4 antibodies

  • Mass cytometry (CyTOF) for multiplexed protein detection

  • Single-cell Western blotting for protein isoform analysis

• Spatial transcriptomics integration:

  • Combined immunofluorescence with in situ RNA detection

  • Correlation of MYH4 protein with MYH4 transcript localization

• Advanced imaging techniques:

  • Super-resolution microscopy for subcellular MYH4 localization

  • Expansion microscopy for enhanced spatial resolution

  • Multiplexed ion beam imaging (MIBI) for highly multiplexed protein detection

These approaches enable researchers to examine muscle fiber heterogeneity at unprecedented resolution, revealing subtleties in fiber type composition that were previously undetectable with conventional methods.

What considerations are important when using MYH4 antibodies in disease model research?

When investigating muscle disorders or disease models:

• Disease-specific changes:

  • Altered MYH4 expression patterns may occur in pathological conditions

  • Modified protein may affect antibody binding (post-translational modifications)

  • Fiber type switching phenomena may complicate interpretation

• Control selection:

  • Age-matched, sex-matched controls are essential

  • Consider region-specific muscle differences

  • Account for exercise history and physical activity levels

• Methodological adaptations:

  • Optimize fixation for potentially fibrotic or altered tissues

  • Adjust antigen retrieval for disease-modified tissues

  • Consider dual or triple staining to contextually interpret changes

Research has demonstrated that MYH4 expression can be dramatically altered in various neuromuscular disorders, during aging, and in response to physiological or pathological stimuli. Careful interpretation requires consideration of these complex regulatory patterns.

How can MYH4 antibodies be used in conjunction with other muscle fiber markers for comprehensive analysis?

Comprehensive muscle analysis often requires multiple markers beyond MYH4:

• Complementary structural proteins:

  • Combine MYH4 with dystrophin or laminin to outline fiber boundaries

  • Include desmin or α-actinin for additional structural context

• Metabolic enzyme markers:

  • Integrate succinate dehydrogenase (SDH) or NADH-TR staining for oxidative capacity

  • Combine with glycolytic enzyme markers for metabolic profiling

• Regulatory factors:

  • Pair with myogenic regulatory factors (MRFs) for developmental studies

  • Include signaling pathway components relevant to fiber type specification

• Multiplexed imaging strategies:

  • Sequential immunostaining with signal removal between rounds

  • Spectral unmixing for simultaneous detection of multiple markers

  • Cyclic immunofluorescence for highly multiplexed imaging

This integrative approach provides a comprehensive view of muscle fiber properties beyond simple type classification, revealing functional specialization and adaptability of muscle fibers under various conditions.